Becton, Dickinson and Co. | BDX - Stock

Aktienkurs
152.14
Täglich Wechseln
-2.71 -1.75%
Monatlich
-3.87%
Jährlich
-25.81%
Q2 Prognose
148.88




Stock Veränderung Datum
Abbott USD 6.49B 220M 2025-12
Agilent USD 1.06B 34M 2025-12
Align Technology USD 228.16M 15.59M 2025-09
AngioDynamics USD 65.57M 3.56M 2025-09
Avanos Medical USD 148M 2.6M 2025-12
Baxter International USD 2.23B 228M 2025-12
Becton, Dickinson and Co. USD 4.08B 191M 2025-12
Bio-Rad Laboratories USD 740.7M 42.5M 2025-12
Boston Scientific USD 2.94B 22M 2025-12
Cooper Companies USD 846M 35M 2025-09
Danaher USD 2.61B 119M 2026-03
Dentsply International USD 642M 44M 2025-12
Dexcom USD 629.1M 25M 2025-12
Edwards Lifesciences USD 1.13B 14.7M 2025-12
Globus Medical USD 759.28M 12.26M 2025-12
Insulet USD 452.6M 6.3M 2025-12
Integra LifeSciences USD 492.73M 3.63M 2025-12
Intuitive Surgical USD 1.95B 105.1M 2026-03
J&J USD 14.58B 392M 2026-03
Masimo USD 338.6M 20.1M 2025-09
Medtronic USD 6.31B 153M 2025-12
Solventum Corp USD 1.07B 17M 2025-12
Stryker USD 5.31B 60M 2025-12
Tandem Diabetes Care USD 128.77M 8.51M 2025-12
Teleflex USD 802.46M 108.78M 2025-09
Terumo JPY 311.91B 10.92B 2025-09
Thermo Fisher Scientific USD 5.5B 71M 2026-03
Zimmer Biomet Holdings USD 2.29B 197.3M 2025-12